OpenAlex 473 works 3 author topics
Works
473 works
-
OpenAlex top 1%
OpenAlex 99.8%
No abstract yet.
-
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer 2020YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.5%
Chemoresistance is a major obstacle in triple negative breast cancer (TNBC), the most aggressive breast cancer subtype. Here we identify hypoxia-induced ECM re-modeler, lysyl oxidase (LOX) as a key inducer of chemoresistance by developing chemoresistant TNBC tumors in vivo and characterizing their transcriptomes by RN…
-
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer 2020YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.5%
Chemoresistance is a major obstacle in triple negative breast cancer (TNBC), the most aggressive breast cancer subtype. Here we identify hypoxia-induced ECM re-modeler, lysyl oxidase (LOX) as a key inducer of chemoresistance by developing chemoresistant TNBC tumors in vivo and characterizing their transcriptomes by RN…
-
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer 2020YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.5%
Chemoresistance is a major obstacle in triple negative breast cancer (TNBC), the most aggressive breast cancer subtype. Here we identify hypoxia-induced ECM re-modeler, lysyl oxidase (LOX) as a key inducer of chemoresistance by developing chemoresistant TNBC tumors in vivo and characterizing their transcriptomes by RN…
-
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer 2020YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.5%
Chemoresistance is a major obstacle in triple negative breast cancer (TNBC), the most aggressive breast cancer subtype. Here we identify hypoxia-induced ECM re-modeler, lysyl oxidase (LOX) as a key inducer of chemoresistance by developing chemoresistant TNBC tumors in vivo and characterizing their transcriptomes by RN…
-
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer 2020YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.5%
Chemoresistance is a major obstacle in triple negative breast cancer (TNBC), the most aggressive breast cancer subtype. Here we identify hypoxia-induced ECM re-modeler, lysyl oxidase (LOX) as a key inducer of chemoresistance by developing chemoresistant TNBC tumors in vivo and characterizing their transcriptomes by RN…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex 87.1%
No abstract yet.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 1%
OpenAlex 99.9%
BACKGROUND: Belzutifan, a hypoxia-inducible factor 2α inhibitor, showed clinical activity in clear-cell renal-cell carcinoma in early-phase studies. METHODS: In a phase 3, multicenter, open-label, active-controlled trial, we enrolled participants with advanced clear-cell renal-cell carcinoma who had previously receive…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 10%
OpenAlex 97.7%
No abstract yet.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 10%
OpenAlex 96.6%
In this study, the polyphenol oxidase (PPO) of artichoke (Cynara scolymus L.) was first purified by a combination of (NH(4))(2)SO(4) precipitation, dialysis, and a Sepharose 4B-L-tyrosine-p-aminobenzoic acid affinity column. At the end of purification, 43-fold purification was achieved. The purified enzyme migrated as…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 10%
OpenAlex 96.5%
In this study, the polyphenol oxidase (PPO) of artichoke (Cynara scolymus L.) was first purified by a combination of (NH(4))(2)SO(4) precipitation, dialysis, and a Sepharose 4B-L-tyrosine-p-aminobenzoic acid affinity column. At the end of purification, 43-fold purification was achieved. The purified enzyme migrated as…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 10%
OpenAlex 96.6%
In this study, the polyphenol oxidase (PPO) of artichoke (Cynara scolymus L.) was first purified by a combination of (NH(4))(2)SO(4) precipitation, dialysis, and a Sepharose 4B-L-tyrosine-p-aminobenzoic acid affinity column. At the end of purification, 43-fold purification was achieved. The purified enzyme migrated as…
Academicians
3 academicians